Widely used GLP-1 medications prescribed for weight loss and type 2 diabetes have recently been linked to an unexpected side effect affecting patients' fingernails. The class of drugs involved includes well-known treatments such as Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, and Trulicity.
While these therapies are primarily known for helping regulate blood sugar levels and supporting significant weight reduction, observations have connected their use to surprising nail-related issues. Patients and clinicians are noting changes in fingernail health during the course of treatment.
Individuals currently taking any GLP-1 medications who notice unusual changes or problems with their fingernails are encouraged to consult their healthcare provider for evaluation and personalized medical guidance.
Source Attribution: Article content originally reported by Science Daily. Read original story coverage on Science Daily →
